JPRN-jRCT2080222905未知2 期
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients confirmed to have various types of cancer who were informed about their disease.
排除标准
- •- Patients with abnormalities at the planned application site.
- •- Patients with a serious hematologic disorder, hepatic dysfunction, renal dysfunction, hypertension, or heart failure.
- •- Patients who have undergone an operation or nerve block, etc. that may affect assessment of pain.
研究者
相似试验
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
未知
2 期
Phase II clinical study in patients with Parkinson's disease.Parkinson's diseaseJPRN-jRCT2080221631Hisamitsu Pharmaceutical Co., Inc.
进行中（未招募）
不适用
A pilot Phase II study of PHA-739358 in patients with Chronic Myeloid Leukemia relapsing on Gleevec or c-ABL therapy - NDTreatment of Chronic Myeloid LeukemiaMedDRA version: 9.1Level: LLTClassification code 10009013Term: Chronic myeloid leukaemiaEUCTR2006-006881-40-ITERVIANO MEDICAL SCIENCES16
未知
3 期
ong-term study of HP-3000 in patients with Parkinson's diseaseParkinson's diseaseJPRN-jRCT2080222696Hisamitsu Pharmaceutical Co.,Inc.
未知
1 期
Phase I/II study of HP-3060 in patients with allergic rhinitis.Allergic rhinitisJPRN-jRCT2080222141Hisamitsu Pharmaceutical Co., Inc.